Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
Abroad (travel likely)Active Not RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Non-Small Cell Lung Cancer
Locations
- Research Site, Duarte, California, United States
- Research Site, Los Angeles, California, United States
- Research Site, Sacramento, California, United States
- Research Site, Santa Monica, California, United States
- Research Site, New Haven, Connecticut, United States
- Research Site, Chicago, Illinois, United States
- Research Site, Baltimore, Maryland, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, Grand Rapids, Michigan, United States
- Research Site, New York, New York, United States
- Research Site, New York, New York, United States
- Research Site, Portland, Oregon, United States
- Research Site, Pittsburgh, Pennsylvania, United States
- Research Site, Houston, Texas, United States
- Research Site, Seattle, Washington, United States
- Research Site, Odense C, Denmark
- Research Site, Catania, Italy
- Research Site, Naples, Italy
- Research Site, Orbassano, Italy
- Research Site, Padova, Italy
- Research Site, Varese, Italy
- Research Site, Chūōku, Japan
- Research Site, Fukuoka, Japan
- Research Site, Kōtoku, Japan
- Research Site, Nagoya, Japan
- Research Site, Osaka, Japan
- Research Site, Wakayama, Japan
- Research Site, Amsterdam, Netherlands
- Research Site, Amsterdam, Netherlands
- Research Site, Maastricht, Netherlands
- Research Site, Nijmegen, Netherlands
- Research Site, Rotterdam, Netherlands
- Research Site, Drammen, Norway
- Research Site, Oslo, Norway
- Research Site, Trondheim, Norway
- Research Site, Seongnam-si, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, A Coruña, Spain
- Research Site, Barcelona, Spain
- Research Site, Barcelona, Spain
- Research Site, Madrid, Spain
- Research Site, Madrid, Spain
- Research Site, Seville, Spain
- Research Site, Stockholm, Sweden